20 May 2013
Keywords: avanir, shares, rocket, fda, appeal, pays, off
Article | 04 November 1999
Avanir Pharmaceuticals, which has spent months trying to get approvalfor its oral-facial herpes drug docosanol in the USA, looks to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 November 1999
5 November 1999
© 2013 thepharmaletter.com